Achtung! Das Lehrangebot ist noch nicht vollständig und wird bis Semesterbeginn laufend ergänzt.

323008 SE Case Studies in Drug Discovery and Preclinical Drug Development - MPS7 (2020S)

(1 Course)

5.00 ECTS (1.00 SWS), SPL 32 - Pharmazie

Prüfungsimmanente Lehrveranstaltung

Moodle

Details

Sprache: Englisch

Lehrende

Termine (iCal) - nächster Termin ist mit N markiert

Mittwoch 22.04. 10:00 - 11:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Mittwoch 22.04. 13:30 - 15:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Freitag 22.05. 09:00 - 11:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Montag 15.06. 09:00 - 11:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II

Information

Ziele, Inhalte und Methode der Lehrveranstaltung

Students will work in small teams to conceptualise concrete drug development project proposals and to discuss and revise their proposals with the supervisors. The proposal topic will involve a real project conducted in industry. The outcomes from the industry research project will be revealed in the final lecture. The course will consist of two lectures, 3 assignments, and 3 feedback/discussion sessions.

Art der Leistungskontrolle und erlaubte Hilfsmittel

Students must attend all sessions and actively participate in the discussion, complete and submit all of the assignments. They are expected to incorporate feedback and discussion outcomes into their revised final project proposal due before the last day of class.

Mindestanforderungen und Beurteilungsmaßstab

Course attendance; completion of assignments including revisions from feedback sessions to be submitted to instructors for evaluation. Final presentation on last day of course and final revised proposal to be handed in to instructors.

Prüfungsstoff

Literatur

To be given in class

Zuordnung im Vorlesungsverzeichnis

MPS7 Case Studies in Drug Discovery und Preclinical Drug Development (5 ECTS)

Master Drug Discovery and Development (606)

Letzte Änderung: Sa 02.04.2022 00:27